Santhera Pharmaceuticals Holding (SANN) Revenue

4 Followers

Statistics Market Cap Revenue

Santhera Pharmaceuticals Holding Revenue

Santhera Pharmaceuticals Holding had a revenue of 53.17M in the quarter ending Mar 31, 2026, with 121.43%. This bring the company's revenue in the last twelve months to 77.19M, Decreased 57.47%. In the fiscal year ending Mar 31, 2026, Santhera Pharmaceuticals Holding had annual revenue of 77.19M with 97.32% growth.

Revenue (ttm)

77.19M

Revenue Growth

97.32%

P/S Ratio

3.32

Revenue/Employee

CHF989,551

Employees

Market Cap

CHF256.41M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	77.19M	38.07M	+97.32%
Mar 31, 2025	39.12M	-64.30M	-62.17%
Dec 31, 2023	103.41M	95.94M	+1,283.84%
Mar 31, 2023	7.47M	9.07M	-568.53%
Dec 31, 2021	-1.59M	-16.60M	-110.63%
Dec 31, 2020	15.01M	-60.37M	-80.09%
Dec 31, 2019	75.38M	43.72M	+138.10%
Dec 31, 2018	31.66M	8.71M	+37.98%
Dec 31, 2017	22.94M	―	―